# Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

Study · id `cardio:ct-nct01958320` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01958320](<https://clinicaltrials.gov/study/NCT01958320>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01958320

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

## Technical summary

Registry record NCT01958320. Randomized; single masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2017-06 (actual). Results posted on 2018-11-30.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 202 participants (enrolled count; ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Start date: 2013-12 (registry gives no type) (ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Primary completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Results first posted: 2018-11-30 (ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Countries: United States; Sweden; Türkiye; United Kingdom (ClinicalTrials.gov record NCT01958320, source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01958320-2018-11-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
- Acronym: PDA:TOLERATE
- Condition: Patent Ductus Arteriosus
- Condition: Surgery
- Condition: Necrotizing Enterocolitis
- Condition: Intestinal Perforation
- Intervention (Other): pharmacologic treatment of the PDA
- Intervention (Other): no pharmacologic treatment of the PDA
- Intervention (Drug): NSAID
- Lead sponsor: University of California, San Francisco
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age (`cardio:pubmed-30340932`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320) (`cardio:pubmed-30850756`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fdea38f9c7270b04763702265205fe276a88798dd7b60f01f0c1501fbb888c3d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
